You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康健國際醫療(03886.HK)2020年淨虧2.81億港元
格隆匯 03-27 00:27

格隆匯 3 月 27日丨康健國際醫療(03886.HK)公吿,截至2020年12月31日止年度全年業績,收入同比減少5%至10.69億港元;股東應占虧損2.81億港元,同比擴大3240.12%;每股虧損3.73港仙。

2020年,2019冠狀病毒病疫情的爆發對公眾健康造成嚴重威脅,作為醫療系統的前線機構,全力做好防疫抗疫工作是集團年內的重要目標。集團從員工的防護裝備、診所和醫院的清潔消毒、通報機制等多方面着手,上下齊心努力抗疫,在香港和內地都實現"零感染"的目標。同時,集團亦積極配合協助政府進行2019冠狀病毒病檢測,並聯合政府認可的醫療檢測機構合作開設一間2019冠狀病毒病核酸檢測化驗中心,為香港規模大的該類別化驗中心一,為提升香港的核酸檢測能力,長遠減低疫情大規模爆發的風險貢獻一分力。

香港疫情不斷反覆,對經濟帶來持續衝擊,經濟復甦過程緩慢而艱難。由於疫情未受控,市民外出意欲降低,減低求診次數,影響集團於香港地區的業務表現。面對疫情帶來的嚴峻挑戰,集團靈活調整運營管理策略,開源節流嚴控開支。

內地業務方面,得益於內地疫情持續得到有效控制、經濟實現快速復甦,集團內地業務也逐步有序恢復,最終獲得令人鼓舞的增長。與此同時,經過數年與中國人壽集團的深度合作,協同效應更為顯著,為集團帶來更大價值。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account